Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 16647 matches for

LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases.

Elucidating the mechanisms driving epicardial quiescence to reveal novel targets for cardiac regeneration

Understanding the pathological role of neuropeptide Y in myocardial ischemia-reperfusion

Investigation of a novel player in lymphatic valve development and lymphoedema

Investigation of ADPRHL1 (ARH2), a disease modifier in hypertrophic cardiomyopathy

Variant-specific alterations of myocardial metabolism in patient-derived iPSC-cardiomyocyte models of hypertrophic cardiomyopathy

Mechanism of action of a novel HD2 mutation

High throughput GPCR characterisation utilising Presto-Tango

Implementing transportable hyperpolarized Xenon to expand cardiac-pulmonary functional imaging research.

Investigating a novel gene in endothelial resistance

Dissecting the aetiology of sarcomere-negative hypertrophic cardiomyopathy using convolutional neural network analysis

Development of a human vascularised cardiac organoid system for modelling cell-cell interactions and target discovery in heart disease

Manipulating local phosphodiesterase activity to improve cardiac function

Mechanosensitive adaptor proteins in vascular pathology

Effects of paced heart rate on cerebral blood flow velocity and pulsatility

Myocardial inflammation modelling in iPSC-derived human cardiac organoids

Equipment support for BHF Intermediate Fellowship

Matching in vivo to ex vivo human coronary microvascular function

Impact of the sex-dependence of propionate metabolism on the emergence of novel histone modifications

Targeting cardiovascular disease with peptide inhibitors of chemokines

Uncovering novel regulators of angiogenesis

Load More

Similar stories